Golden has been acquired by ComplyAdvantage.Read about it here ⟶

List of Rxi Pharmaceuticals Corporation patents

List of Rxi Pharmaceuticals Corporation patents

List of Sense Photonics patents

List of Cumberland Pharmaceuticals patents

List of Front Edge Technology patents

List of funding rounds for Lalamove

List of companies in SK Inc.'s investment portfolio

Patents where

Current Assignee

Name

is

‌

Rxi Pharmaceuticals Corporation

	Name	Description	Patent Applicant	Current Assignee	Inventor	Patent Jurisdiction	Patent Number	Date of Patent
	‌ US Patent 10131904 Modified RNAi polynucleotides and uses thereof	Patent 10131904 was granted and assigned to Rxi Pharmaceuticals Corporation on November, 2018 by the United States Patent and Trademark Office.		‌ Rxi Pharmaceuticals Corporation		United States Patent and Trademark Office	10131904	November 20, 2018
	‌ US Patent 10167471 Inhibition of PCSK9 through RNAI	Patent 10167471 was granted and assigned to Rxi Pharmaceuticals Corporation on January, 2019 by the United States Patent and Trademark Office.	‌ Rxi Pharmaceuticals Corporation	‌ Rxi Pharmaceuticals Corporation		United States Patent and Trademark Office	10167471	January 1, 2019
	‌ US Patent 9074211 Inhibition of MAP4K4 through RNAI	Patent 9074211 was granted and assigned to Rxi Pharmaceuticals Corporation on July, 2015 by the United States Patent and Trademark Office.		‌ Rxi Pharmaceuticals Corporation		United States Patent and Trademark Office	9074211	July 7, 2015
	‌ US Patent 10041073 Reduced size self-delivering RNAi compounds	Patent 10041073 was granted and assigned to Rxi Pharmaceuticals Corporation on August, 2018 by the United States Patent and Trademark Office.		‌ Rxi Pharmaceuticals Corporation		United States Patent and Trademark Office	10041073	August 7, 2018
	‌ US Patent 10138485 Neutral nanotransporters	Patent 10138485 was granted and assigned to Rxi Pharmaceuticals Corporation on November, 2018 by the United States Patent and Trademark Office.		‌ Rxi Pharmaceuticals Corporation		United States Patent and Trademark Office	10138485	November 27, 2018
	‌ US Patent 9175289 Reduced size self-delivering RNAi compounds	Patent 9175289 was granted and assigned to Rxi Pharmaceuticals Corporation on November, 2015 by the United States Patent and Trademark Office.	‌ Rxi Pharmaceuticals Corporation	‌ Rxi Pharmaceuticals Corporation		United States Patent and Trademark Office	9175289	November 3, 2015
	‌ US Patent 9340786 RNA interference in dermal and fibrotic indications	Patent 9340786 was granted and assigned to Rxi Pharmaceuticals Corporation on May, 2016 by the United States Patent and Trademark Office.		‌ Rxi Pharmaceuticals Corporation		United States Patent and Trademark Office	9340786	May 17, 2016
	‌ US Patent 9303259 RNA interference in skin indications	Patent 9303259 was granted and assigned to Rxi Pharmaceuticals Corporation on April, 2016 by the United States Patent and Trademark Office.	‌ Rxi Pharmaceuticals Corporation	‌ Rxi Pharmaceuticals Corporation		United States Patent and Trademark Office	9303259	April 5, 2016
	‌ US Patent 8664189 RNA interference in skin indications	Patent 8664189 was granted and assigned to Rxi Pharmaceuticals Corporation on March, 2014 by the United States Patent and Trademark Office.		‌ Rxi Pharmaceuticals Corporation		United States Patent and Trademark Office	8664189	March 4, 2014
	‌ US Patent 9745574 RNA duplexes with single stranded phosphorothioate nucleotide regions for additional functionality	Patent 9745574 was granted and assigned to Rxi Pharmaceuticals Corporation on August, 2017 by the United States Patent and Trademark Office.		‌ Rxi Pharmaceuticals Corporation		United States Patent and Trademark Office	9745574	August 29, 2017
	‌ US Patent 9963702 RNA interference in dermal and fibrotic indications	Patent 9963702 was granted and assigned to Rxi Pharmaceuticals Corporation on May, 2018 by the United States Patent and Trademark Office.	‌ Rxi Pharmaceuticals Corporation	‌ Rxi Pharmaceuticals Corporation		United States Patent and Trademark Office	9963702	May 8, 2018
	‌ US Patent 8796443 Reduced size self-delivering RNAi compounds	Patent 8796443 was granted and assigned to Rxi Pharmaceuticals Corporation on August, 2014 by the United States Patent and Trademark Office.		‌ Rxi Pharmaceuticals Corporation		United States Patent and Trademark Office	8796443	August 5, 2014
	‌ US Patent 8815818 Phagocytic cell delivery of RNAI	Patent 8815818 was granted and assigned to Rxi Pharmaceuticals Corporation on August, 2014 by the United States Patent and Trademark Office.		‌ Rxi Pharmaceuticals Corporation		United States Patent and Trademark Office	8815818	August 26, 2014
	‌ US Patent 9938530 RNA interference in skin indications	Patent 9938530 was granted and assigned to Rxi Pharmaceuticals Corporation on April, 2018 by the United States Patent and Trademark Office.	‌ Rxi Pharmaceuticals Corporation	‌ Rxi Pharmaceuticals Corporation		United States Patent and Trademark Office	9938530	April 10, 2018

14 results

0 selected

14 results

0 selected